{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:34:37Z","timestamp":1791326077349,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jhep.2017.01.009","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T08:31:23Z","timestamp":1485160283000},"page":"919-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication"],"prefix":"10.1016","volume":"66","author":[{"given":"Michelle J.","family":"Farquhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isla S.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Rudge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrick K.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishnupriya","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ciaccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Balfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Roessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.O.","family":"Wakelam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"McKeating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.01.009_b0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0034-1371007","article-title":"New hepatitis C virus (HCV) drugs and the hope for a cure: concepts in anti-HCV drug development","volume":"34","author":"Pawlotsky","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.01.009_b0010","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2017.01.009_b0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution","volume":"65","author":"Reig","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.01.009_b0020","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/S0021-9258(18)45911-X","article-title":"Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein","volume":"267","author":"Stracke","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2017.01.009_b0025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.plipres.2015.02.001","article-title":"Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer","volume":"58","author":"Barbayianni","year":"2015","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jhep.2017.01.009_b0030","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QAI.0b013e3182909847","article-title":"Plasma proteome analysis reveals overlapping, yet distinct mechanisms of immune activation in chronic HCV and HIV infections","volume":"63","author":"Schlatzer","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jhep.2017.01.009_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-9-71","article-title":"Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma","volume":"9","author":"Wu","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jhep.2017.01.009_b0040","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s11605-007-0322-9","article-title":"Is autotaxin (ENPP2) the link between hepatitis C and hepatocellular cancer?","volume":"11","author":"Cooper","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhep.2017.01.009_b0045","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cca.2014.03.006","article-title":"Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma","volume":"433","author":"Kondo","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jhep.2017.01.009_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103532","article-title":"Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis\u2013a prospective cohort study","volume":"9","author":"Pleli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.01.009_b0055","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.24485","article-title":"Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts","volume":"54","author":"Mazzocca","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.01.009_b0060","doi-asserted-by":"crossref","first-page":"10249","DOI":"10.1128\/JVI.00763-07","article-title":"Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor","volume":"81","author":"Nasimuzzaman","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.01.009_b0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jhep.2011.11.018","article-title":"A dual role for hypoxia inducible factor-1alpha in the hepatitis C virus lifecycle and hepatoma migration","volume":"56","author":"Wilson","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.01.009_b0070","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2017.01.009_b0075","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/hep.25870","article-title":"Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors","volume":"56","author":"Neumann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.01.009_b0080","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","article-title":"A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients","volume":"70","author":"Roessler","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2017.01.009_b0085","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1158\/1078-0432.CCR-09-3274","article-title":"A seven-gene set associated with chronic hypoxia of prognostic importance in hepatocellular carcinoma","volume":"16","author":"van Malenstein","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2017.01.009_b0090","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.1001529107","article-title":"Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation","volume":"107","author":"Albers","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2017.01.009_b0095","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.1128\/JVI.01059-06","article-title":"Production of infectious hepatitis C virus by well-differentiated, growth-arrested human hepatoma-derived cells","volume":"80","author":"Sainz","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.01.009_b0100","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1124\/mol.64.4.994","article-title":"Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors","volume":"64","author":"Ohta","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2017.01.009_b0105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI78794","article-title":"Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance","volume":"125","author":"Bailey","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2017.01.009_b0110","doi-asserted-by":"crossref","first-page":"25244","DOI":"10.1074\/jbc.M113.489708","article-title":"Regulation of hypoxia-inducible factor 1alpha (HIF-1alpha) by lysophosphatidic acid is dependent on interplay between p53 and Kruppel-like factor 5","volume":"288","author":"Lee","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2017.01.009_b0115","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/bjc.2012.131","article-title":"The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function","volume":"106","author":"Baker","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2017.01.009_b0120","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1158\/1078-0432.CCR-06-1252","article-title":"Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression","volume":"12","author":"Lee","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2017.01.009_b0125","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1128\/JVI.79.14.8742-8749.2005","article-title":"Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication","volume":"79","author":"Mannova","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.01.009_b0130","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3892\/ijmm.2012.1096","article-title":"Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT","volume":"30","author":"Chen","year":"2012","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jhep.2017.01.009_b0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/labinvest.2013.156","article-title":"Modulation of PI3K-LXRalpha-dependent lipogenesis mediated by oxidative\/nitrosative stress contributes to inhibition of HCV replication by quercetin","volume":"94","author":"Pisonero-Vaquero","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2017.01.009_b0140","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/JVI.02534-12","article-title":"Low oxygen tension enhances hepatitis C virus replication","volume":"87","author":"Vassilaki","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2017.01.009_b0145","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1089\/ten.tea.2013.0487","article-title":"Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis","volume":"20","author":"Binder","year":"2014","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.jhep.2017.01.009_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/srep16406","article-title":"Lysophosphatidic acid enhances survival of human CD34(+) cells in ischemic conditions","volume":"5","author":"Kostic","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2017.01.009_b0155","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/bjc.2013.787","article-title":"HBx mutants differentially affect the activation of hypoxia-inducible factor-1alpha in hepatocellular carcinoma","volume":"110","author":"Liu","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2017.01.009_b0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.01.009_b0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2009.04.029","article-title":"Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells","volume":"284","author":"Jansen","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhep.2017.01.009_b0170","first-page":"105","article-title":"Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis","volume":"143","author":"Muro","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2017.01.009_b0175","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/blood-2005-02-0471","article-title":"Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells","volume":"106","author":"Baumforth","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2017.01.009_b0180","doi-asserted-by":"crossref","first-page":"9870","DOI":"10.1158\/0008-5472.CAN-06-1679","article-title":"EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells","volume":"66","author":"Kondo","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2017.01.009_b0185","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1476-5381.2010.00815.x","article-title":"Aiming drug discovery at lysophosphatidic acid targets","volume":"161","author":"Tigyi","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2017.01.009_b0190","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4155\/fmc.13.154","article-title":"Development of lysophosphatidic acid pathway modulators as therapies for fibrosis","volume":"5","author":"Budd","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.jhep.2017.01.009_b0195","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1158\/0008-5472.CAN-14-1607","article-title":"Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma","volume":"75","author":"Mazzocca","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2017.01.009_b0200","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbalip.2012.08.015","article-title":"Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy","volume":"1831","author":"Brindley","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2017.01.009_b0205","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1517\/13543776.2013.796364","article-title":"Autotaxin inhibitors: a patent review","volume":"23","author":"Barbayianni","year":"2013","journal-title":"Expert Opin Ther Patents"},{"key":"10.1016\/j.jhep.2017.01.009_b0210","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1128\/MCB.02419-05","article-title":"Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development","volume":"26","author":"van Meeteren","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2017.01.009_b0215","doi-asserted-by":"crossref","first-page":"25822","DOI":"10.1074\/jbc.M605142200","article-title":"Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid","volume":"281","author":"Tanaka","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2017.01.009_b0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ydbio.2010.01.007","article-title":"ATX expression and LPA signalling are vital for the development of the nervous system","volume":"339","author":"Fotopoulou","year":"2010","journal-title":"Dev Biol"},{"key":"10.1016\/j.jhep.2017.01.009_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143083","article-title":"The bulk of autotaxin activity is dispensable for adult mouse life","volume":"10","author":"Katsifa","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817300132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817300132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T14:17:21Z","timestamp":1658499441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817300132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0168827817300132"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.01.009","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}